Logo image of CPSH

CPS TECHNOLOGIES CORP (CPSH) Stock Fundamental Analysis

NASDAQ:CPSH - Nasdaq - US12619F1049 - Common Stock - Currency: USD

2.8  -0.06 (-2.1%)

Fundamental Rating

3

Overall CPSH gets a fundamental rating of 3 out of 10. We evaluated CPSH against 125 industry peers in the Electronic Equipment, Instruments & Components industry. While CPSH has a great health rating, there are worries on its profitability. CPSH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CPSH has reported negative net income.
In the past year CPSH has reported a negative cash flow from operations.
Of the past 5 years CPSH 4 years were profitable.
CPSH had a positive operating cash flow in 4 of the past 5 years.
CPSH Yearly Net Income VS EBIT VS OCF VS FCFCPSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

CPSH's Return On Assets of -15.08% is on the low side compared to the rest of the industry. CPSH is outperformed by 67.20% of its industry peers.
CPSH has a Return On Equity of -19.68%. This is in the lower half of the industry: CPSH underperforms 62.40% of its industry peers.
Industry RankSector Rank
ROA -15.08%
ROE -19.68%
ROIC N/A
ROA(3y)-0.15%
ROA(5y)5.52%
ROE(3y)-0.05%
ROE(5y)7.72%
ROIC(3y)N/A
ROIC(5y)N/A
CPSH Yearly ROA, ROE, ROICCPSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With a Gross Margin value of 0.91%, CPSH is not doing good in the industry: 90.40% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for CPSH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CPSH Yearly Profit, Operating, Gross MarginsCPSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

8

2. Health

2.1 Basic Checks

CPSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CPSH remains at a similar level compared to 1 year ago.
CPSH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CPSH has been reduced compared to a year ago.
CPSH Yearly Shares OutstandingCPSH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CPSH Yearly Total Debt VS Total AssetsCPSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 4.69 indicates that CPSH is not in any danger for bankruptcy at the moment.
CPSH has a Altman-Z score of 4.69. This is in the better half of the industry: CPSH outperforms 72.00% of its industry peers.
There is no outstanding debt for CPSH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.69
ROIC/WACCN/A
WACC8.93%
CPSH Yearly LT Debt VS Equity VS FCFCPSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

CPSH has a Current Ratio of 3.29. This indicates that CPSH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CPSH (3.29) is better than 66.40% of its industry peers.
CPSH has a Quick Ratio of 2.21. This indicates that CPSH is financially healthy and has no problem in meeting its short term obligations.
CPSH has a Quick ratio of 2.21. This is in the better half of the industry: CPSH outperforms 63.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.21
CPSH Yearly Current Assets VS Current LiabilitesCPSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

CPSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -502.02%.
Looking at the last year, CPSH shows a very negative growth in Revenue. The Revenue has decreased by -13.85% in the last year.
CPSH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.33% yearly.
EPS 1Y (TTM)-502.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)-13.85%
Revenue growth 3Y-2.01%
Revenue growth 5Y-0.33%
Sales Q2Q%27.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPSH Yearly Revenue VS EstimatesCPSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CPSH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CPSH Price Earnings VS Forward Price EarningsCPSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPSH Per share dataCPSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CPSH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CPS TECHNOLOGIES CORP

NASDAQ:CPSH (6/27/2025, 8:00:00 PM)

2.8

-0.06 (-2.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29
Inst Owners21.51%
Inst Owner Change3.02%
Ins Owners12.13%
Ins Owner Change1.68%
Market Cap40.68M
Analysts0
Price TargetN/A
Short Float %1.57%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.79
P/FCF N/A
P/OCF N/A
P/B 2.76
P/tB 2.76
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS1.56
BVpS1.01
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.08%
ROE -19.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.91%
FCFM N/A
ROA(3y)-0.15%
ROA(5y)5.52%
ROE(3y)-0.05%
ROE(5y)7.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 134.99%
Cap/Sales 3.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 2.21
Altman-Z 4.69
F-Score1
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)142.12%
Cap/Depr(5y)119.05%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-502.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.85%
Revenue growth 3Y-2.01%
Revenue growth 5Y-0.33%
Sales Q2Q%27.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-636.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-312.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-251.34%
OCF growth 3YN/A
OCF growth 5YN/A